ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 2

Featuring perspectives from Dr Matthew Goetz, including the following topics: Introduction (0:00) Case: A woman in her late 30s with a 3-cm, weakly ER-positive, PR-negative, HER2-negative, node-positive infiltrating ductal carcinoma (IDC) — Nick C Leasure, MD (22:01) Case: A premenopausal woman in her late 40s with ER/PR-positive, HER2-negative, node-positive IDC — Reshma Mahtani, DO (29:59) Case: A woman in her late 60s with de novo ER/PR-positive, HER2-negative metastatic breast cancer (mBC) — Benjamin Parsons, DO (42:10) Case: A postmenopausal woman in her early 50s with de novo ER/PR-positive, HER2-negative mBC with a PIK3CA mutation — Dr Mahtani (53:50) SABCS 2021 Preview (57:51) CME information and select publications